Citigroup’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Buy
393,895
+217,669
+124% +$12.7M 0.01% 1002
2025
Q4
$10.5M Buy
176,226
+1,551
+0.9% +$84.4K 0.01% 1494
2025
Q3
$9.46M Sell
174,675
-6,298
-3% -$360K 0.01% 1527
2025
Q2
$9.95M Sell
180,973
-88,094
-33% -$5.19M 0.01% 1371
2025
Q1
$19M Buy
269,067
+50,613
+23% +$3.41M 0.01% 1000
2024
Q4
$14.4M Buy
218,454
+11,254
+5% +$754K 0.01% 1157
2024
Q3
$14.6M Buy
207,200
+37,517
+22% +$3.14M 0.01% 1127
2024
Q2
$14M Sell
169,683
-52,691
-24% -$4.39M 0.01% 1077
2024
Q1
$19.4M Buy
222,374
+31,582
+17% +$2.83M 0.02% 892
2023
Q4
$18.4M Sell
190,792
-18,316
-9% -$1.62M 0.02% 891
2023
Q3
$18.5M Sell
209,108
-7,746
-4% -$689K 0.03% 800
2023
Q2
$18.8M Sell
216,854
-52,752
-20% -$4.96M 0.02% 850
2023
Q1
$26.2M Buy
269,606
+90,762
+51% +$9.41M 0.04% 690
2022
Q4
$18.5M Sell
178,844
-33,171
-16% -$3.11M 0.03% 836
2022
Q3
$18M Buy
212,015
+32,579
+18% +$2.9M 0.03% 828
2022
Q2
$14.9M Buy
179,436
+58,316
+48% +$4.64M 0.02% 938
2022
Q1
$9.34M Sell
121,120
-194,424
-62% -$16.3M 0.01% 1336
2021
Q4
$27.9M Buy
315,544
+76,314
+32% +$6.3M 0.03% 842
2021
Q3
$18.5M Sell
239,230
-14,603
-6% -$1.15M 0.02% 1052
2021
Q2
$21.2M Sell
253,833
-7,177
-3% -$569K 0.02% 970
2021
Q1
$19.7M Buy
261,010
+29,854
+13% +$2.44M 0.02% 964
2020
Q4
$20.3M Sell
231,156
-28,807
-11% -$2.28M 0.02% 1021
2020
Q3
$19.8M Sell
259,963
-5,204
-2% -$527K 0.03% 904
2020
Q2
$32.7M Buy
265,167
+25,653
+11% +$2.55M 0.05% 558
2020
Q1
$20.2M Buy
239,514
+1,540
+0.6% +$133K 0.04% 731
2019
Q4
$20.1M Sell
237,974
-220
-0.1% -$16.6K 0.03% 968
2019
Q3
$16.1M Buy
238,194
+67,113
+39% +$5.17M 0.03% 1066
2019
Q2
$14.7M Buy
171,081
+21,755
+15% +$1.86M 0.02% 1131
2019
Q1
$13.3M Buy
149,326
+4,756
+3% +$441K 0.02% 1078
2018
Q4
$12.3M Buy
144,570
+14,874
+11% +$1.41M 0.03% 1124
2018
Q3
$12.6M Buy
129,696
+4,189
+3% +$418K 0.02% 1132
2018
Q2
$11.8M Buy
125,507
+90,255
+256% +$7.9M 0.02% 1163
2018
Q1
$2.86M Sell
35,252
-10,254
-23% -$880K 0.01% 2293
2017
Q4
$4.06M Buy
45,506
+12,723
+39% +$1.11M 0.01% 2034
2017
Q3
$3.05M Sell
32,783
-59,738
-65% -$5.28M 0.01% 2217
2017
Q2
$8.4M Buy
92,521
+28,379
+44% +$2.58M 0.02% 1275
2017
Q1
$5.63M Sell
64,142
-115,369
-64% -$10.3M 0.01% 1565
2016
Q4
$14.9M Buy
179,511
+126,342
+238% +$10.9M 0.03% 937
2016
Q3
$4.92M Buy
53,169
+6,348
+14% +$598K 0.01% 1687
2016
Q2
$3.64M Sell
46,821
-21,902
-32% -$1.86M 0.01% 1856
2016
Q1
$5.67M Sell
68,723
-1,929
-3% -$157K 0.01% 1446
2015
Q4
$7.4M Sell
70,652
-55,871
-44% -$5.83M 0.02% 1382
2015
Q3
$13.3M Sell
126,523
-5,819
-4% -$777K 0.03% 944
2015
Q2
$18.1M Buy
132,342
+50,516
+62% +$6.26M 0.03% 838
2015
Q1
$10.2M Buy
81,826
+31,251
+62% +$3.31M 0.02% 1167
2014
Q4
$4.57M Sell
50,575
-59,417
-54% -$4.94M 0.01% 1863
2014
Q3
$7.94M Buy
109,992
+31,496
+40% +$2.07M 0.01% 1474
2014
Q2
$4.88M Buy
78,496
+47,245
+151% +$2.85M 0.01% 1816
2014
Q1
$2.13M Buy
31,251
+6,054
+24% +$446K ﹤0.01% 2313
2013
Q4
$1.77M Sell
25,197
-20,442
-45% -$1.39M ﹤0.01% 2686
2013
Q3
$3.3M Buy
45,639
+18,160
+66% +$1.21M 0.01% 2103
2013
Q2
$1.53M Buy
+27,479
New +$1.71M ﹤0.01% 2565

Other funds holding BMRN